good news and bad news about Vioxx

May 2002

The good news and bad news about Vioxx is creating questions.

Rheumatoid arthritis. Vioxx (rofecoxib) is now approved for symptoms of rheumatoid arthritis in adults...25 mg once a day.

GI safety. The FDA now allows Merck to say that Vioxx reduces the risk of GI bleeding and perforations compared to naproxen.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote